GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avecho Biotechnology Ltd (OTCPK:AVEFF) » Definitions » EV-to-FCF

AVEFF (Avecho Biotechnology) EV-to-FCF : -1.33 (As of Jan. 19, 2025)


View and export this data going back to 2006. Start your Free Trial

What is Avecho Biotechnology EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Avecho Biotechnology's Enterprise Value is $3.04 Mil. Avecho Biotechnology's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was $-2.28 Mil. Therefore, Avecho Biotechnology's EV-to-FCF for today is -1.33.

The historical rank and industry rank for Avecho Biotechnology's EV-to-FCF or its related term are showing as below:

AVEFF' s EV-to-FCF Range Over the Past 10 Years
Min: -16.4   Med: -1.55   Max: 36.19
Current: -1.44

During the past 13 years, the highest EV-to-FCF of Avecho Biotechnology was 36.19. The lowest was -16.40. And the median was -1.55.

AVEFF's EV-to-FCF is ranked worse than
100% of 395 companies
in the Biotechnology industry
Industry Median: 7.5 vs AVEFF: -1.44

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-01-19), Avecho Biotechnology's stock price is $0.0014. Avecho Biotechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.001. Therefore, Avecho Biotechnology's PE Ratio (TTM) for today is At Loss.


Avecho Biotechnology EV-to-FCF Historical Data

The historical data trend for Avecho Biotechnology's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avecho Biotechnology EV-to-FCF Chart

Avecho Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.71 -31.25 -7.38 -15.34 -1.81

Avecho Biotechnology Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -15.34 - -1.81 -

Competitive Comparison of Avecho Biotechnology's EV-to-FCF

For the Biotechnology subindustry, Avecho Biotechnology's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avecho Biotechnology's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avecho Biotechnology's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Avecho Biotechnology's EV-to-FCF falls into.



Avecho Biotechnology EV-to-FCF Calculation

Avecho Biotechnology's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3.038/-2.278
=-1.33

Avecho Biotechnology's current Enterprise Value is $3.04 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Avecho Biotechnology's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was $-2.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avecho Biotechnology  (OTCPK:AVEFF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Avecho Biotechnology's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0014/-0.001
=At Loss

Avecho Biotechnology's share price for today is $0.0014.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Avecho Biotechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.001.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Avecho Biotechnology EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Avecho Biotechnology's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Avecho Biotechnology Business Description

Traded in Other Exchanges
Address
Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology TPM, for the pharmaceutical, skincare and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

Avecho Biotechnology Headlines

No Headlines